Baird lowered the firm’s price target on Novanta to $150 from $169 and keeps a Neutral rating on the shares. The firm said the company is positioning a strong new product intro cycle to ramp late-24/25 as a catalyst to help re-ignite sales and the pending Motion Solutions acquisition fits well, will add meaningful revenue to CY24E, with EPS accretion to ramp meaningfully in 2025 and beyond.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NOVT:
